ImmunoBiome

South Korea
Pohang, Gyeongsangbuk-do, South Korea, 37666

Company profile

ImmunoBiome company profile

ImmunoBiome aims to develop microbiome therapeutics to treat incurable diseases like cancer and autoimmune diseases based on our top-notch immunology, bioinformatics, and microbiome-oriented basic research.

Business identity

Contact email
[email protected]
Phone number
+82-10-6890-7352
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2019-06-20

Headquarters

Postal code
37666
Country code
KR
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$27.2M
Last funding
Series B / $18M / 2021-09-23
Last equity funding
Series B / $18M
Investors
8
Lead investors
1
Founders
1
Articles
8

Founders and investors

Founders

Sin-Hyeog Im

Lead investors

Korea Investment Partners

Investors

Aju IB InvestmentCompany K PartnersDSC InvestmentKorea Investment PartnersKorea Investment & Securities